Scientists have designed a new method for post-operative wound closing and healing that is both fast and effective. This strategy revolves around engineered “cell sheets”—or layers of skin-based cells. The procedure culminates in a wound dressing that is custom made for a specific cut or lesion that can be used to effectively treat open skin areas after surgeries.
Read MoreThe Central Palm Beach County Chamber of Commerce held a networking mixer at the Center for Wound Care and Hyperbaric Medicine at Wellington Regional Medical Center on Wednesday, Sept. 11. There was a tour of the facility and an explanation of the services offered. Refreshments were served.
Read MoreThis post hoc analysis evaluates the association between the frequency of diabetic foot ulcer (DFU) debridement and the proportion of ulcers treated with active continuous diffusion of oxygen (CDO) that heal in a 12-week evaluation period.
Read MoreCardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced U.S. Food and Drug Administration (FDA) PMA approval of the new ViperWire Advance® Coronary Guide Wire with Flex Tip (ViperWire Advance with Flex Tip).
Read MoreSeptember is Peripheral Artery Disease Awareness month. Peripheral artery disease affects as many as 12 million people in the United States, and increases in prevalence with age. One in every eight Americans older than 60 years of age have PAD but only 25% of the general population is aware of the disease, which is why HSHS St. Anthony’s Memorial Hospital’s Wound Healing Center wants to educate the community on this critical health issue.
Read MoreA recent study found that being a smoker, having diabetes, and also having a history of coronary heart disease or stroke increases the lifetime risk for PAD by as much as five times that of someone of the same race, age, and sex who does not have those risk factors.
Read MoreLimFlow said today that it won an investigational device exemption from the FDA for a pivotal trial of its catheter-based intervention for a severe form of peripheral artery disease. LimFlow’s percutaneous deep vein arterialization device is designed to re-route blood flow from a blocked artery through the venous system to deliver oxygenated blood to the foot and lower leg.
Read MoreHealogics®, the nation’s wound expert, today announced that it has appointed Rob Doll to serve as Chief Marketing Officer. In this role, Doll will be responsible for all aspects of Healogics marketing strategy, including expansion of the company’s brand and new innovative solutions furthering Healogics outreach into the healthcare community.
Read MoreKerecis, the company pioneering the use of fish skin in tissue regeneration, today announced the results of a new prospective case study of Kerecis Omega3 Burn. The study, announced at the American Burn Association annual meeting, found that patients with partial-thickness burn and donor-site wounds healed quickly, with no infection, after treatment with the fish-skin graft.
Read MoreStafford Hospital physicians, leaders and clinicians are celebrating the Robert A. Warriner III, M.D., Center of Excellence award, given to the Stafford Hospital Wound Healing Center of Woodbridge.
Read More